Conditions Treated

Theranostics  shows promising results and is FDA-approved for metastatic cancer that does not respond to other therapies. If your cancer is widespread and can be targeted by radioactive tracers, you may be a candidate for theranostics. This therapy is currently FDA-approved for:

• Neuroendocrine tumors
• Advanced prostate cancer

Thernostics treatment for other conditions is under investigation.

Learn more about Clinical Trials at the Willis Knighton Cancer Center